The Second Edition offers the reader the very latest information on lipid disorders from aetiology to the management of this ever increasing problem that is a major cause of atherosclerotic and cardiovascular disease. Written by a general practitioner, an epidemiologist, and a lipidologist, this concise and well-illustrated text will appeal to a wi
After half a century of doubt and debate, dyslipidemia has at last been accepted by cardiologists and the medical community at large as a major, treatable cause of atherosclerotic cardiovascular disease. A number of guidelines have been issued on the management of dyslipidemia in preventing coronary heart disease. A working knowledge of the various types of dyslipidemia and their treatment is highly relevant to modern medicine, with its accent on prevention. This book, written by a general practitioner, an epidemiologist, and a lipidologist, provides a broad and up-to-date perspective of dyslipidemia and is chiefly intended for use in primary care. It details normal lipid metabolism, describes the genetic and acquired causes of dyslipidemia and reviews the evidence that the latter is a risk factor for vascular disease. Most of the book, however, is devoted to the practicalities of screening, risk assessment and management of dyslipidemia in everyday clinical practice, including chapters summarizing current guidelines, the importance of diet and the role of lipid-lowering drugs. Cardiologists, general practitioners and pharmacists will find this volume indispensable.
The Second Edition offers the reader the very latest information on lipid disorders from aetiology to the management of this ever increasing problem that is a major cause of atherosclerotic and cardiovascular disease. Written by a general practitioner, an epidemiologist, and a lipidologist, this concise and well-illustrated text will appeal to a wi
After half a century of doubt and debate, dyslipidemia has at last been accepted by cardiologists and the medical community at large as a major, treatable cause of atherosclerotic cardiovascular disease. A number of guidelines have been issued on the management of dyslipidemia in preventing coronary heart disease. A working knowledge of the various types of dyslipidemia and their treatment is highly relevant to modern medicine, with its accent on prevention. This book, written by a general practitioner, an epidemiologist, and a lipidologist, provides a broad and up-to-date perspective of dyslipidemia and is chiefly intended for use in primary care. It details normal lipid metabolism, describes the genetic and acquired causes of dyslipidemia and reviews the evidence that the latter is a risk factor for vascular disease. Most of the book, however, is devoted to the practicalities of screening, risk assessment and management of dyslipidemia in everyday clinical practice, including chapters summarizing current guidelines, the importance of diet and the role of lipid-lowering drugs. Cardiologists, general practitioners and pharmacists will find this volume indispensable.
Offering unparalleled coverage of infectious diseases in children and adolescents, Feigin & Cherry’s Textbook of Pediatric Infectious Diseases 8th Edition, continues to provide the information you need on epidemiology, public health, preventive medicine, clinical manifestations, diagnosis, treatment, and much more. This extensively revised edition by Drs. James Cherry, Gail J. Demmler-Harrison, Sheldon L. Kaplan, William J. Steinbach, and Peter J. Hotez, offers a brand-new full-color design, new color images, new guidelines, and new content, reflecting today’s more aggressive infectious and resistant strains as well as emerging and re-emerging diseases Discusses infectious diseases according to organ system, as well as individually by microorganisms, placing emphasis on the clinical manifestations that may be related to the organism causing the disease. Provides detailed information regarding the best means to establish a diagnosis, explicit recommendations for therapy, and the most appropriate uses of diagnostic imaging. Features expanded information on infections in the compromised host; immunomodulating agents and their potential use in the treatment of infectious diseases; and Ebola virus. Contains hundreds of new color images throughout, as well as new guidelines, new resistance epidemiology, and new Global Health Milestones. Includes new chapters on Zika virus and Guillain-Barré syndrome. Expert ConsultTM eBook version included with purchase. This enhanced eBook experience allows you to search all of the text, figures, and references from the book on a variety of devices.
Meningiomas, by M. Necmettin Pamir, MD, Peter M. Black, MD, PhD, and Rudolf Fahlbusch, MD, presents current and comprehensive guidance on this most common, yet clinically challenging type of brain tumor. Written and edited by the world’s most prominent brain tumor neurosurgeons, it helps you to not only determine the type and location of the tumor, but also the most ideal surgical approach to provide your patients with the best outcomes. An extensive collection of surgical photographs covers unique and original cases, while discussions of pre-surgical techniques and approaches emphasize decision making with the help of all imaging modalities and analysis of symptoms and patient history. Expert Consult functionality enhances your reference power with convenient online access to the complete text and illustrations from the book, along with videos that depict surgical techniques in real time. Provides access to the complete text online—fully searchable, along with all of the illustrations downloadable for your personal presentations, and real-time surgical videos covering microscopic extended endonasal approach to suprasellar meningioma, and more, at expertconsult.com. Covers today’s full range of management methods, including adjuvant therapies, providing you with the best strategies for obtaining optimal outcomes. Features the work of the world’s most prominent brain tumor neurosurgeons—a completely international authorship—bringing you the best procedures globally. Offers an in-depth section on surgical methods and approaches based upon tumor location, to help you in the decision-making process. Includes coverage of spinal meningiomas including pre-diagnosis symptoms and outcomes.
It is one of the world's great fortunes, the empire founded by Sam Bronfman and carried on through his family, a kingdom worth more than $7 billion nurtured on bootleg alcohol and sustained through decades of deals, scandals, legal explosions and intrafamily warfare. At its heart is the Seagram Company Ltd., the world's largest distilling operation, responsible for more than one million bottles of liquor per day sold in the U.S. alone, but its reach stretches far beyond that--to oil companies, hotels, mines, factories and real estate all over the world. Except that they are almost certainly richer and without a doubt more secretive, the Bronfmans have become the Rothschilds of the New World, and here at last is the extraordinary story of their lives, times and turbulent fortunes, chronicled by best-selling journalist Peter C. Newman. -- From publisher's description.
The Action Plan for Australian Mammals 2012 is the first review to assess the conservation status of all Australian mammals. It complements The Action Plan for Australian Birds 2010 (Garnett et al. 2011, CSIRO Publishing), and although the number of Australian mammal taxa is marginally fewer than for birds, the proportion of endemic, extinct and threatened mammal taxa is far greater. These authoritative reviews represent an important foundation for understanding the current status, fate and future of the nature of Australia. This book considers all species and subspecies of Australian mammals, including those of external territories and territorial seas. For all the mammal taxa (about 300 species and subspecies) considered Extinct, Threatened, Near Threatened or Data Deficient, the size and trend of their population is presented along with information on geographic range and trend, and relevant biological and ecological data. The book also presents the current conservation status of each taxon under Australian legislation, what additional information is needed for managers, and the required management actions. Recovery plans, where they exist, are evaluated. The voluntary participation of more than 200 mammal experts has ensured that the conservation status and information are as accurate as possible, and allowed considerable unpublished data to be included. All accounts include maps based on the latest data from Australian state and territory agencies, from published scientific literature and other sources. The Action Plan concludes that 29 Australian mammal species have become extinct and 63 species are threatened and require urgent conservation action. However, it also shows that, where guided by sound knowledge, management capability and resourcing, and longer-term commitment, there have been some notable conservation success stories, and the conservation status of some species has greatly improved over the past few decades. The Action Plan for Australian Mammals 2012 makes a major contribution to the conservation of a wonderful legacy that is a significant part of Australia’s heritage. For such a legacy to endure, our society must be more aware of and empathetic with our distinctively Australian environment, and particularly its marvellous mammal fauna; relevant information must be readily accessible; environmental policy and law must be based on sound evidence; those with responsibility for environmental management must be aware of what priority actions they should take; the urgency for action (and consequences of inaction) must be clear; and the opportunity for hope and success must be recognised. It is in this spirit that this account is offered.
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.